Freebird Partners LP

Insider Reports History

Location
Houston, TX
Signature
Freebird Partners LP, By: Freebird Investments LLC, its general partner, By: /s/ Curtis W. Huff, Chairman and President
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Freebird Partners LP:

Company Role Class Num Shares Value Price $ Report Date Ownership
Eterna Therapeutics Inc. 10%+ Owner Convertible Note Shares 783,233 $1,503,337 $1.92 15 Dec 2023 Direct
Comera Life Sciences Holdings, Inc. 10%+ Owner Convertible Note Shares 2,453,636 $134,950 $0.0550 29 Dec 2023 Direct
Comera Life Sciences Holdings, Inc. 10%+ Owner Common Stock Purchase Warrant 7,362,005 29 Dec 2023 Direct
Eterna Therapeutics Inc. 10%+ Owner Common Stock Purchase Warrant 1,991,394 15 Dec 2023 Direct
Comera Life Sciences Holdings, Inc. 10%+ Owner Common Stock, par value $0.0001 per share 1,254,776 03 Dec 2023 Direct
Eterna Therapeutics Inc. 10%+ Owner Common Stock, par value $0.005 per share 272,582 03 Apr 2023 Direct

Insider Reports Filed by Freebird Partners LP

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000095017024001385-freebird-partners-lp-2023-12-29 Comera Life Sciences Holdings, Inc. 29 Dec 2023 2 +$134,950 4 10%+ Owner 03 Jan 2024, 20:09
ERNA Eterna Therapeutics Inc. 14 Dec 2023 6 +$1,000,000 4 10%+ Owner 18 Dec 2023, 21:38
/report/000095017024001364-freebird-partners-lp-2023-12-03 Comera Life Sciences Holdings, Inc. 03 Dec 2023 0 $0 3 10%+ Owner 03 Jan 2024, 19:40
ERNA Eterna Therapeutics Inc. 14 Jul 2023 2 +$749,998 4 10%+ Owner 18 Jul 2023, 06:10
ERNA Eterna Therapeutics Inc. 03 Apr 2023 0 $0 3 10%+ Owner 04 Apr 2023, 17:03